Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.


Reset Filter

2154 search results for ‘*’

Manufacture Bioprocessing - Upstream & Downstream

Advanced recombinant DNA engineering strategies

| Sponsored by Nibrt

Discover the latest advanced recombinant DNA engineering strategies for improved phenotypic stability and selection of producer lines

Manufacture Bioprocessing - Upstream & Downstream

Cell Viability

| Sponsored by Nibrt

Is there a case for re-evaluating cell viability in bioprocesses?

Manufacture Advanced Medicine

Hot Topics at CAR-TCR 2020

| James Strachan

In what may have been one of the last advanced therapy meetings to go ahead for some time, delegates met in London in late February for CAR-TCR.

Business & Regulation Standards & Regulation

Pro Bono Advice

| Maryam Mahdi

The EMA is offering scientists free advice on the development of therapeutics to treat COVID-19.

Manufacture Dosage Forms

The Forensic Troubleshooter

Sitting Down With... Stephen Tindal, Director, Science & Technology at Catalent Pharma Solutions, to discuss his career in troubleshooting.

Continuous Wet Granulation and Fluid-bed Drying – An Experimental Investigation of a New Revolutionary System

| Contributed by LB Bohle

Continuous wet granulation and drying have long been a hot topic in pharmaceutical research and development (R&D) and industry.

Discovery & Development Drug Discovery

The Bumpy Road to a Cytomegalovirus Vaccine

The development of a CMV vaccine has been 50 years in the making.

Discovery & Development Drug Discovery

Sticks and Stones

| Maryam Mahdi

Novosteo has developed a targeted drug combination to help accelerate the repair of bone fractures.

Discovery & Development Drug Discovery

The Battle Against the Brain-Eating Amoeba

| Maryam Mahdi

Novel compounds could be effective in treating brain-eating amoeba.

Reduce Downstream Processing Costs for mAbs by Switching to Tosoh’s 2-Step Platform

| Contributed by Tosoh

Downstream processing is responsible for up to 80 percent of the entire production costs of biotherapeutics.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine